Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE2
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
- Status
- RECRUITING
- Phase
- PHASE3
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Pharmacological Ascorbate for Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
- Status
- COMPLETED
- Phase
- N/A